Clinical Trials Directory

Trials / Completed

CompletedNCT03768323

Airtime Incentive Amounts to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

A Randomized Controlled Trial of Varying Airtime Incentive Amounts to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Uganda

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,233 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effect of two different airtime incentive amounts on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to control group, in Bangladesh and Uganda.

Detailed description

Using random digit dialing sampling techniques, the investigators randomized random digit dialed (RDD) participants to one of three airtime incentive amounts contingent on them completing the noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study was conducted in both Bangladesh and Uganda

Conditions

Interventions

TypeNameDescription
OTHER1X airtime incentivean incentive given in the form of airtime to motivate participants to complete the survey. Participants were given 50 Bangladeshi Taka ($0.60 USD) or 5000 Ugandan Shillings (UGX; $1.35 USD as of April 3, 2018) worth of airtime for completing the survey
OTHER2X airtime incentivean incentive given in the form of airtime to motivate participants to complete the survey. Participants were given 100 Bangladeshi Taka ($1.20 USD) or 10000 UGX ($2.70 USD) worth of airtime for completing the survey

Timeline

Start date
2017-03-26
Primary completion
2017-07-14
Completion
2017-07-14
First posted
2018-12-07
Last updated
2018-12-10

Locations

2 sites across 2 countries: Bangladesh, Uganda

Source: ClinicalTrials.gov record NCT03768323. Inclusion in this directory is not an endorsement.